Thiazolopyrimidinone Derivative H5–23 Enhances Daptomycin Activity against Linezolid-Resistant <i>Enterococcus faecalis</i> by Disrupting the Cell Membrane-Reference-Cited by-同舟云学术

Thiazolopyrimidinone Derivative H5–23 Enhances Daptomycin Activity against Linezolid-Resistant Enterococcus faecalis by Disrupting the Cell Membrane

Published:2023-11-28 Issue:12 Volume:9 Page:2523-2537
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Xiong Yanpeng¹²^ORCID,Chen Zhong²^ORCID,Bai Bing²,Peng Yalan¹,Liu Shanghong²,Fang Di¹,Wen Zewen²^ORCID,Shang Yongpeng²,Lin Zhiwei²³,Han Shiqing¹,Yu Zhijian²

Affiliation:

1. College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China

2. Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen Nanshan People’s Hospital and the Sixth Affiliated Hospital of Shenzhen University Medical School, Shenzhen 518052, China

3. Laboratory of Respiratory Disease, People’s Hospital of Yangjiang, Yangjiang 529500, China

Funder

Basic and Applied Basic Research Foundation of Guangdong Province

Science, Technology and Innovation Commission of Shenzhen Municipality

National Natural Science Foundation of China

Shenzhen Key Medical Discipline Construction Fund

Provincial medical funds of Guangdong

Shenzhen Nanshan District Scientific Research Program of the People?s Republic of China

Jiangsu Synergetic Innovation Center for Advanced Bio- Manufacture

Publisher

American Chemical Society (ACS)

Subject